Chemoinformaics analysis of 2-Oxo-kolavenic acid
| Molecular Weight | 318.457 | nRot | 4 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 14 |
| Exact Molecular Weight | 318.219 | nRing | 2 |
| Solubility: LogS | -3.67 | nHRing | 0 |
| Solubility: LogP | 3.404 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 55.8098 |
| nHD | 1 | BPOL | 31.8322 |
| QED | 0.759 |
| Synth | 4.219 |
| Natural Product Likeliness | 3.009 |
| NR-PPAR-gamma | 0.159 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.677 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -5.15 |
| MDCK | 0.0000228 |
| BBB | 0.204 |
| PPB | 0.920816 |
| VDSS | 0.495 |
| FU | 0.0737964 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.771 |
| CYP2c19-inh | 0.102 |
| CYP2c19-sub | 0.824 |
| CYP2c9-inh | 0.347 |
| CYP2c9-sub | 0.721 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.257 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.298 |
| CL | 0.818 |
| T12 | 0.877 |
| hERG | 0.018 |
| Ames | 0.006 |
| ROA | 0.051 |
| SkinSen | 0.964 |
| Carcinogencity | 0.12 |
| EI | 0.93 |
| Respiratory | 0.949 |
| NR-Aromatase | 0.597 |
| Antiviral | Yes |
| Prediction | 0.587555 |